litlas
ログインアカウント作成

John E. Shively

1970–2024 年に発表

121
論文数
18,141
被引用数
87
h 指数
119
i10 指数

被引用数

John E. Shively の年別被引用数1970 年: 被引用 1 件1971 年: 被引用 3 件1972 年: 被引用 1 件1973 年: 被引用 2 件1974 年: 被引用 2 件1975 年: 被引用 5 件1976 年: 被引用 5 件1978 年: 被引用 6 件1979 年: 被引用 10 件1980 年: 被引用 17 件1981 年: 被引用 28 件1982 年: 被引用 44 件1983 年: 被引用 51 件1984 年: 被引用 91 件1985 年: 被引用 79 件1986 年: 被引用 102 件1987 年: 被引用 109 件1988 年: 被引用 111 件1989 年: 被引用 142 件1990 年: 被引用 166 件1991 年: 被引用 145 件1992 年: 被引用 103 件1993 年: 被引用 108 件1994 年: 被引用 98 件1995 年: 被引用 136 件1996 年: 被引用 145 件1997 年: 被引用 164 件1998 年: 被引用 146 件1999 年: 被引用 161 件2000 年: 被引用 139 件2001 年: 被引用 110 件2002 年: 被引用 123 件2003 年: 被引用 110 件2004 年: 被引用 113 件2005 年: 被引用 154 件2006 年: 被引用 110 件2007 年: 被引用 127 件2008 年: 被引用 132 件2009 年: 被引用 127 件2010 年: 被引用 101 件2011 年: 被引用 86 件2012 年: 被引用 97 件2013 年: 被引用 84 件2014 年: 被引用 63 件2015 年: 被引用 62 件2016 年: 被引用 61 件2017 年: 被引用 49 件2018 年: 被引用 54 件2019 年: 被引用 180 件2020 年: 被引用 216 件2021 年: 被引用 241 件2022 年: 被引用 174 件2023 年: 被引用 156 件2024 年: 被引用 253 件2025 年: 被引用 88 件2026 年: 被引用 5 件1977 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,373 件、この内訳の 40.1%イギリス: 引用元論文 367 件、この内訳の 6.2%中国: 引用元論文 364 件、この内訳の 6.2%ドイツ: 引用元論文 329 件、この内訳の 5.6%日本: 引用元論文 328 件、この内訳の 5.6%フランス: 引用元論文 213 件、この内訳の 3.6%カナダ: 引用元論文 200 件、この内訳の 3.4%スウェーデン: 引用元論文 186 件、この内訳の 3.1%スイス: 引用元論文 158 件、この内訳の 2.7%オーストラリア: 引用元論文 149 件、この内訳の 2.5%イタリア: 引用元論文 133 件、この内訳の 2.3%オランダ: 引用元論文 127 件、この内訳の 2.1%
0%40.1%その他 16.6%

機関

分野

  • Biochemistry, Genetics and Molecular Biology40.7%
  • Medicine36.3%
  • Immunology and Microbiology7.5%
  • Neuroscience5.8%
  • Pharmacology, Toxicology and Pharmaceutics4.4%
  • Chemistry1.1%
  • その他4.2%

トピック

  • Monoclonal and Polyclonal Antibodies Research4%
  • Glycosylation and Glycoproteins Research2.8%
  • Inflammasome and immune disorders2.8%
  • Radiopharmaceutical Chemistry and Applications2.8%
  • Cell death mechanisms and regulation2.7%
  • Pharmacogenetics and Drug Metabolism2.1%
  • その他82.8%

共著者

全論文

検索で開く
  1. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

    著者: Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay, Kevin T. Chapman, Andrew Howard, Matthew J. Kostura, Douglas K. Miller, Susan M. Molineaux, Jeffrey R. Weidner, John Auniņš, Keith Elliston, Julia M. Ayala, Francesca J. Casano, Jayne Chin, G J Ding, Linda A. Egger, Erin P. Gaffney, G Limjuco, Oksana Palyha, S Raju, Anna Rolando, J. Paul Salley, Ting-Ting Yamin, Terry D. Lee, John E. Shively, Malcolm MacCross, Richard A. Mumford, John A. Schmidt, Michael J. Tocci - Nature 1992 被引用: 2,580

  2. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction—Measurement by ELISA

    著者: Shozo Yokoyama, Akihiro Takeuchi, Shunsuke Yamaguchi, Yasuyuki Mitani, Takashi Watanabe, Kenji Matsuda, Tsukasa Hotta, John E. Shively, Hiroki Yamaue - PLoS ONE 2017 被引用: 108

  3. Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells

    著者: John P. Murad, Anna Kozłowska, Hee Jun Lee, Maya Ramamurthy, Wen-Chung Chang, Paul J. Yazaki, David Colcher, John E. Shively, Mihaela Cristea, Stephen J. Forman, Saul J. Priceman - Frontiers in Immunology 2018 被引用: 146

  4. Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

    著者: Joanne Mortimer, James R. Bading, Jinha Park, Paul Frankel, Mary Carroll, Tri Manh Tran, Erasmus Poku, Russell C. Rockne, Andrew Raubitschek, John E. Shively, David Colcher - Journal of Nuclear Medicine 2017 被引用: 95

  5. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

    著者: Domenico Viola, Ada Donà, Enrico Caserta, Estelle Troadec, Francesca Besi, Tinisha McDonald, Lucy Ghoda, Emine Gulsen Gunes, James F. Sanchez, Jihane Khalife, Marianna Martella, Chatchada Karanes, Myo Htut, Xiuli Wang, Michael Rosenzweig, Arnab Chowdhury, Douglas W. Sborov, Rodney R. Miles, Paul J. Yazaki, Todd Ebner, Craig C. Hofmeister, Stephen J. Forman, Steven T. Rosen, Guido Marcucci, John E. Shively, Jonathan J. Keats, Amrita Krishnan, Flavia Pichiorri - Leukemia 2020 被引用: 88

  6. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine

    著者: Michael R. Weist, Renate Starr, Brenda Aguilar, Junie Chea, Joshua K. Miles, Erasmus Poku, Ethan Gerdts, Xin Yang, Saul J. Priceman, Stephen J. Forman, David Colcher, Christine E. Brown, John E. Shively - Journal of Nuclear Medicine 2018 被引用: 170

  7. Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophils

    著者: Zhifang Zhang, Gregory Cherryholmes, Frances Chang, David M. Rose, Ingrid U. Schraufstätter, John E. Shively - European Journal of Immunology 2009 被引用: 116

  8. Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study

    著者: Joanne Mortimer, James R. Bading, Paul Frankel, Mary Carroll, Yuan Yuan, Jinha Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Poku, John E. Shively, David Colcher - Journal of Nuclear Medicine 2021 被引用: 35

  9. The HopQ-CEACAM Interaction Controls CagA Translocation, Phosphorylation, and Phagocytosis of Helicobacter pylori in Neutrophils

    著者: Ina‐Kristin Behrens, Benjamin Busch, Hellen Ishikawa‐Ankerhold, Pia Palamides, John E. Shively, Cliff Stanners, Carlos H.F. Chan, Nelly Leung, Scott D. Gray‐Owen, Rainer Haas - mBio 2020 被引用: 49

  10. Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

    著者: Vikram Adhikarla, Dennis Awuah, Enrico Caserta, Megan Minnix, Maxim Kuznetsov, Amrita Krishnan, Jefferey Y. C. Wong, John E. Shively, Xiuli Wang, Flavia Pichiorri, Russell C. Rockne - Frontiers in Immunology 2024 被引用: 19

  11. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues.

    著者: Bon‐chu Chung, J Picado-Leonard, Mitsuru Haniu, Michał Bieńkowski, Peter F. Hall, John E. Shively, W L Miller - National Academy of Sciences, Proceedings of the National Academy of Sciences 1987 被引用: 451

  12. Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth

    著者: Sorah Yoon, Kai‐Wen Huang, Vikash Reebye, Duncan Spalding, Teresa M. Przytycka, Yijie Wang, Piotr Swiderski, Lin Li, Brian Armstrong, Isabella Reccia, Dimitris Zacharoulis, Konstantinos Dimas, Tomokazu Kusano, John E. Shively, Nagy Habib, John J. Rossi - Molecular Therapy — Nucleic Acids 2016 被引用: 79

  13. Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine

    著者: Seung E. Cha, Maciej Kujawski, Paul J. Yazaki, Christine E. Brown, John E. Shively - OncoImmunology 2021 被引用: 46

  14. Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab

    著者: Amrita Krishnan, Vikram Adhikarla, Erasmus Poku, Joycelynne Palmer, Ammar Chaudhry, Van Eric Biglang-awa, Nicole Bowles, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Chatchada Karanes, Jennifer Simpson, James F. Sanchez, Dave Yamauchi, Maria Parayno, Arnab Chowdhury, Enrico Caserta, Guido Marcucci, Russell C. Rockne, Anna M. Wu, Jeffrey Y.C. Wong, Stephen J. Forman, David Colcher, Paul J. Yazaki, John E. Shively, Flavia Pichiorri - Blood Advances 2020 被引用: 46

  15. Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

    著者: Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell C. Rockne, John E. Shively, Flavia Pichiorri - Journal of Nuclear Medicine 2020 被引用: 40

  16. Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET

    著者: Joanne Mortimer, James R. Bading, David Colcher, Peter S. Conti, Paul Frankel, Mary Carroll, Shan Tong, Erasmus Poku, Joshua K. Miles, John E. Shively, Andrew Raubitschek - Journal of Nuclear Medicine 2013 被引用: 159

  17. CEACAM1 Negatively Regulates IL-1β Production in LPS Activated Neutrophils by Recruiting SHP-1 to a SYK-TLR4-CEACAM1 Complex

    著者: Rongze Lu, Hao Pan, John E. Shively - PLoS Pathogens 2012 被引用: 79

  18. Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes Therapies

    著者: Junfeng Li, Hirotake Komatsu, Erasmus Poku, Tove Olafsen, Kelly X. Huang, Lina A. Huang, Junie Chea, Nicole Bowles, Betty Chang, Jeffrey Rawson, Jiangling Peng, Anna M. Wu, John E. Shively, Fouad Kandeel - Pharmaceuticals 2022 被引用: 17

  19. Cell Type and Culture Condition–Dependent Alternative Splicing in Human Breast Cancer Cells Revealed by Splicing-Sensitive Microarrays

    著者: Chunxia Li, Mitsuo Kato, Lily Shiue, John E. Shively, Manuel Ares, Ren-Jang Lin - Cancer Research 2006 被引用: 97

  20. Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies

    著者: David Akhavan, Paul J. Yazaki, Dave Yamauchi, Jennifer Simpson, Paul Frankel, James R. Bading, David Colcher, Kofi Poku, Yi‐Jen Chen, Dean Lim, Mihaela Cristea, Anna M. Wu, John E. Shively, Jeffrey Y.C. Wong - Cancer Biotherapy and Radiopharmaceuticals 2020 被引用: 28

  21. A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy

    著者: Vikram Adhikarla, Dennis Awuah, Alexander B. Brummer, Enrico Caserta, Amrita Krishnan, Flavia Pichiorri, Megan Minnix, John E. Shively, Jeffrey Y.C. Wong, Xiuli Wang, Russell C. Rockne - Cancers 2021 被引用: 17

  22. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

    著者: David Pearson, John E. Shively, Brian R. Clark, Irving I. Geschwind, Marylynn Barkley, R.S. Nishioka, Howard A. Bern - National Academy of Sciences, Proceedings of the National Academy of Sciences 1980 被引用: 393

  23. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

    著者: Songhua Hu, L Shively, Andrew Raubitschek, Mark A. Sherman, Lawrence E. Williams, J Y Wong, John E. Shively, Anna M. Wu - 1996 被引用: 337

  24. Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer

    著者: Akihiro Takeuchi, Shozo Yokoyama, Mikihito Nakamori, Masaki Nakamura, Toshiyasu Ojima, Shunsuke Yamaguchi, Yasuyuki Mitani, John E. Shively, Hiroki Yamaue - Scientific Reports 2019 被引用: 30